Evidence map›Paper›PMID 31055731›Full record

SynthesisNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2019

Hypertension, seizures, and epilepsy: a review on pathophysiology and management.

Sara Gasparini, Edoardo Ferlazzo, Chiara Sueri, Vittoria Cianci, Michele Ascoli, Salvatore M Cavalli, Ettore Beghi, Vincenzo Belcastro, Amedeo Bianchi, Paolo Benna and 19 more

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers usage is associated with a reduced risk of seizures and epilepsy after ischemic stroke.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Cerebral small vessel disease increases risk for epilepsy: a Mendelian randomization study.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Long-term risk of seizure after posterior reversible encephalopathy syndrome.Annals of clinical and translational neurology · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 11 institutions in 2 countries.

Sara GaspariniMedical and Surgical Sciences Department, School of Medicine, Magna Græcia University of Catanzaro, Viale Europa, Catanzaro, Italy.
Edoardo FerlazzoMedical and Surgical Sciences Department, School of Medicine, Magna Græcia University of Catanzaro, Viale Europa, Catanzaro, Italy.
Chiara SueriRegional Epilepsy Centre, Great Metropolitan Hospital, Via Melacrino, Reggio Calabria, Italy.
Vittoria CianciRegional Epilepsy Centre, Great Metropolitan Hospital, Via Melacrino, Reggio Calabria, Italy.
Michele AscoliRegional Epilepsy Centre, Great Metropolitan Hospital, Via Melacrino, Reggio Calabria, Italy.
Salvatore M CavalliRegional Epilepsy Centre, Great Metropolitan Hospital, Via Melacrino, Reggio Calabria, Italy.
Ettore BeghiDepartment of Neuroscience, IRCCS, Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy.
Vincenzo BelcastroNeurology Unit, S. Anna Hospital, Como, Italy.
Amedeo BianchiDepartment of Neurology and Epilepsy Centre, San Donato Hospital, Arezzo, Italy.
Paolo BennaDepartment of Neurosciences and Mental Health, Città della Salute e della Scienza University Hospital, Torino, Italy.
Roberto CantelloNeurology Unit, Department of Health Sciences, University of Piemonte Orientale, Novara, Italy.
Domenico ConsoliVibo Valentia Health Authority, Vibo Valentia, Italy.
Fabrizio A De FalcoNeurology Unit, Ospedale del Mare, Via Enrico Russo, Naples, Italy.
Giancarlo Di GennaroIRCCS "NEUROMED", Pozzilli, Isernia, Italy.
Antonio GambardellaMedical and Surgical Sciences Department, School of Medicine, Magna Græcia University of Catanzaro, Viale Europa, Catanzaro, Italy.
Gian Luigi GigliNeurology Unit, Department of Medicine (DAME), University of Udine Medical School, Udine, Italy.
Alfonso IudiceDepartment of Clinical and Experimental Medicine, Section of Neurology, University of Pisa, Pisa, Italy.
Angelo LabateMedical and Surgical Sciences Department, School of Medicine, Magna Græcia University of Catanzaro, Viale Europa, Catanzaro, Italy.
Roberto MichelucciIRCCS Institute of Neurological Sciences, Neurology Unit, Bellaria Hospital, Bologna, Italy.
Maurizio PaciaroniStroke Unit and Division of Cardiovascular Medicine, University of Perugia, Perugia, Italy.
Pasquale PalumboLocal Health Unit, Prato, Italy.
Alberto PrimaveraClinical Neurology, Department of Neuroscience (DINOGMI), University of Genoa, IRCCS AOU San Martino-IST, Genoa, Italy.
Ferdinando SartucciDepartment of Clinical and Experimental Medicine, Section of Neurology, University of Pisa, Pisa, Italy.
Pasquale StrianoPediatric Neurology and Muscular Diseases Unit, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, "G. Gaslini" Institute, Genoa, Italy.
Flavio VillaniDepartment of Diagnostics and Applied Technology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Emilio RussoScience of Health Department, School of Medicine, University "Magna Graecia" of Catanzaro, Viale Europa, Catanzaro, Italy.
Giovambattista De SarroScience of Health Department, School of Medicine, University "Magna Graecia" of Catanzaro, Viale Europa, Catanzaro, Italy.
Umberto AgugliaMedical and Surgical Sciences Department, School of Medicine, Magna Græcia University of Catanzaro, Viale Europa, Catanzaro, Italy. u.aguglia@gmail.com.ORCID http://orcid.org/0000-0002-4574-2951
Epilepsy Study Group of the Italian Neurological Society
Magna Graecia University · ITUniversity of Pisa · ITIstituto Neurologico Mediterraneo · ITMario Negri Institute for Pharmacological Research · ITUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITUniversity of Perugia · ITAzienda Ospedaliera Citta' della Salute e della Scienza di Torino · ITFondazione IRCCS Istituto Neurologico Carlo Besta · ITOspedale Policlinico San Martino · ITOspedale San Donato · ITUniversity of Udine · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEpilepsy and hypertension are common chronic conditions, both showing high prevalence in older age groups. This review outlines current experimental and clinical evidence on both direct and indirect role of hypertension in epileptogenesis and discusses the principles of drug treatment in patients with hypertension and epilepsy.

methodsWe selected English-written articles on epilepsy, hypertension, stroke, and cerebrovascular disease until December, 2018.

resultsRenin-angiotensin system might play a central role in the direct interaction between hypertension and epilepsy, but other mechanisms may be contemplated. Large-artery stroke, small vessel disease and posterior reversible leukoencephalopathy syndrome are hypertension-related brain lesions able to determine epilepsy by indirect mechanisms. The role of hypertension as an independent risk factor for post-stroke epilepsy has not been demonstrated. The role of hypertension-related small vessel disease in adult-onset epilepsy has been demonstrated. Posterior reversible encephalopathy syndrome is an acute condition, often caused by a hypertensive crisis, associated with the occurrence of acute symptomatic seizures. Chronic antiepileptic treatment should consider the risk of drug-drug interactions with antihypertensives.

conclusionsCurrent evidence from preclinical and clinical studies supports the vision that hypertension may be a cause of seizures and epilepsy through direct or indirect mechanisms. In both post-stroke epilepsy and small vessel disease-associated epilepsy, chronic antiepileptic treatment is recommended. In posterior reversible encephalopathy syndrome blood pressure must be rapidly lowered and prompt antiepileptic treatment should be initiated.

Indexed as

Cerebral Small Vessel DiseasesEpilepsyHumansHypertensionSeizuresStrokeEpilepsyHypertensionPosterior reversible encephalopathy syndromeSeizuresStroke

Identifiers

PMID31055731
OpenAlexW2943369412

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.